Travere Therapeutics (TVTX) P/S ratio

P/S ratio today
9.3×

Travere Therapeutics (TVTX) trades at 9.3× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 6.9×. That is 17.9% higher than the 5.9× of fiscal 2024. Figures as of 18 Nov 2026, 09:04 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio today
9.3×
P/S ratio, fiscal 2025
6.9×
Change on fiscal 2024
+17.9%
Highest on record
14.1×fiscal 2021
Lowest on record
3.4×fiscal 2019
Fiscal years on record
122014–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Travere Therapeutics P/S ratio, in more detail

Today's figure is 33.7% above the fiscal 2025 year-end.

Across the 12 fiscal year-ends on record (2014–2025), the highest was 14.1× in fiscal 2021 and the lowest 3.4× in fiscal 2019. Today's P/S ratio is higher than at 75% of the 12 fiscal year-ends on record; their median is 6.2×.

History · 12 fiscal years

P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Travere Therapeutics P/S ratio, year by year

Travere Therapeutics (TVTX) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today9.3×—$51.10—
20256.9× 17.9% up$38.21$5.50
20245.9× 28.2% up$17.42$2.96
20234.6× 62.5% down$8.99$1.96
202212.2× 13.0% down$21.03$1.72
202114.1× 115.6% up$31.04$2.20
20206.5× 90.5% up$27.25$4.17
20193.4× 38.4% down$14.20$4.14
20185.6× 5.7% up$22.63$4.06
20175.3× 2.8% down$21.07$4.00
20165.4× 25.2% down$18.93$3.49
20157.3× 33.3% down$19.29$2.66
201410.9×—$12.24$1.13
2013——$7.00—
2012——$3.35—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

P/S ratio at health care companies of similar size

P/S ratio of Travere Therapeutics and comparable companies
CompanyP/S ratio
MiniMed Group MMED1.6×
Adaptive Biotechnologies ADPT16.7×
Heartflow HTFL23.5×
Travere Therapeutics TVTX10.0×
Option Care Health OPCH0.8×

Today's market value divided by revenue for the latest fiscal year. A company whose statements are in another currency than its shares is left out.

More on TVTX

Travere Therapeutics, figure by figure

Travere Therapeutics (TVTX) overview: price, valuation and scorecardAll health care companies by market value

Travere Therapeutics P/S ratio: questions and answers

What is Travere Therapeutics's P/S ratio?

Travere Therapeutics (TVTX) trades at 9.3× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 6.9×. That is 17.9% higher than the 5.9× of fiscal 2024.

Is Travere Therapeutics's P/S ratio high or low compared with its own history?

Today's P/S ratio is higher than at 75% of the 12 fiscal year-ends on record; their median is 6.2×.

What are the highest and lowest P/S ratio figures on record for Travere Therapeutics?

Across the 12 fiscal year-ends on record (2014–2025), the highest was 14.1× in fiscal 2021 and the lowest 3.4× in fiscal 2019.

How is Travere Therapeutics's P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end. For Travere Therapeutics it is on record here for 12 fiscal years, 2014 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Travere Therapeutics (TVTX) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/TVTX/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.